Photoacoustic imaging for investigating tumor hypoxia: a strategic assessment

Theranostics. 2023 May 29;13(10):3346-3367. doi: 10.7150/thno.84253. eCollection 2023.

Abstract

Hypoxia causes the expression of signaling molecules which regulate cell division, lead to angiogenesis, and further, in the tumor microenvironment, promote resistance to chemotherapy and radiotherapy, and induce metastasis. Photoacoustic imaging (PAI) takes advantage of unique absorption characteristics of chromophores in tissues and provides the opportunity to construct images with a high degree of spatial and temporal resolution. In this review, we discuss the physiologic characteristics of tumor hypoxia, and current applications of PAI using endogenous (label free imaging) and exogenous (organic and inorganic) contrast agents. Features of various methods in terms of their efficacy for determining physiologic and proteomic phenomena are analyzed. This review demonstrates that PAI has the potential to understand tumor growth and metastasis development through measurement of regulatory molecule concentrations, oxygen gradients, and vascular distribution.

Keywords: Photoacoustic imaging; angiogenesis; contrast agents; label-free imaging; tumor hypoxia.

Publication types

  • Review

MeSH terms

  • Humans
  • Neoplasms* / diagnostic imaging
  • Optical Imaging / methods
  • Photoacoustic Techniques* / methods
  • Proteomics
  • Tumor Hypoxia
  • Tumor Microenvironment